122 related articles for article (PubMed ID: 36369416)
21. Low-dose craniospinal radiation therapy for medulloblastoma.
Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
[TBL] [Abstract][Full Text] [Related]
22. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
23. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.
Müller K; Mynarek M; Zwiener I; Siegler N; Zimmermann M; Christiansen H; Budach W; Henke G; Warmuth-Metz M; Pietsch T; von Hoff K; von Bueren A; Bode U; Rutkowski S; Kortmann RD; Fleischhack G; Tippelt S
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1019-24. PubMed ID: 24661654
[TBL] [Abstract][Full Text] [Related]
24. [Early and long-term outcomes of treatment in patients with medulloblastoma].
Izmailov TR; Melnik SY
Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(5):57-62. PubMed ID: 34714004
[TBL] [Abstract][Full Text] [Related]
25. Optimization of Craniospinal Irradiation for Pediatric Medulloblastoma Using VMAT and IMRT.
Al-Wassia RK; Ghassal NM; Naga A; Awad NA; Bahadur YA; Constantinescu C
J Pediatr Hematol Oncol; 2015 Oct; 37(7):e405-11. PubMed ID: 26334433
[TBL] [Abstract][Full Text] [Related]
26. The Parotid Gland is an Underrecognized Organ at Risk for Craniospinal Irradiation.
King MT; Modlin L; Million L; Donaldson SS; Gibbs IC; Choi CY; Soltys SG
Technol Cancer Res Treat; 2016 Jun; 15(3):472-9. PubMed ID: 25948323
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma.
Bavle A; Tewari S; Sisson A; Chintagumpala M; Anderson M; Paulino AC
Pediatr Blood Cancer; 2018 Aug; 65(8):e27095. PubMed ID: 29693784
[TBL] [Abstract][Full Text] [Related]
28. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
[TBL] [Abstract][Full Text] [Related]
29. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
[TBL] [Abstract][Full Text] [Related]
30. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
Suzuki S; Kato T; Murakami M
J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
[TBL] [Abstract][Full Text] [Related]
31. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
Ho ESQ; Barrett SA; Mullaney LM
Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
[TBL] [Abstract][Full Text] [Related]
32. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
Massimino M; Sunyach MP; Barretta F; Gandola L; Garegnani A; Pecori E; Spreafico F; Bonneville-Levard A; Meyronet D; Mottolese C; Boschetti L; Biassoni V; Schiavello E; Giussani C; Carrabba G; Diletto B; Pallotti F; Stefini R; Ferrari A; Terenziani M; Casanova M; Luksch R; Meazza C; Podda M; Chiaravalli S; Puma N; Bergamaschi L; Morosi C; Calareso G; Giangaspero F; Antonelli M; Buttarelli FR; Frappaz D
J Neurooncol; 2020 Jul; 148(3):619-628. PubMed ID: 32567042
[TBL] [Abstract][Full Text] [Related]
33. Permanent alopecia after cranial irradiation: dose-response relationship.
Lawenda BD; Gagne HM; Gierga DP; Niemierko A; Wong WM; Tarbell NJ; Chen GT; Hochberg FH; Loeffler JS
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):879-87. PubMed ID: 15465206
[TBL] [Abstract][Full Text] [Related]
34. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
[TBL] [Abstract][Full Text] [Related]
35. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors.
Murphy ES; Merchant TE; Wu S; Xiong X; Lukose R; Wright KD; Qaddoumi I; Armstrong GT; Broniscer A; Gajjar A
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e655-60. PubMed ID: 22768993
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
[TBL] [Abstract][Full Text] [Related]
37. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma.
Lew SM; Morgan JN; Psaty E; Lefton DR; Allen JC; Abbott R
J Neurosurg; 2006 Feb; 104(2 Suppl):103-7. PubMed ID: 16506497
[TBL] [Abstract][Full Text] [Related]
38. Medulloblastoma: time-dose relationship based on a 30-year review.
del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
[TBL] [Abstract][Full Text] [Related]
39. Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children.
Yuh GE; Loredo LN; Yonemoto LT; Bush DA; Shahnazi K; Preston W; Slater JM; Slater JD
Cancer J; 2004; 10(6):386-90. PubMed ID: 15701271
[TBL] [Abstract][Full Text] [Related]
40. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation.
Reddick WE; Russell JM; Glass JO; Xiong X; Mulhern RK; Langston JW; Merchant TE; Kun LE; Gajjar A
Magn Reson Imaging; 2000 Sep; 18(7):787-93. PubMed ID: 11027871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
